Nu öppnar vi SCAPIS

Välkommen till invigning den 17 mars kl. 15.00-16.15. Programledare Karin Hübinette med gäster kommer att presentera SCAPIS och ge en inblick i världens just nu största hjärt-lungstudie.

Se studioprogrammet här

The Swedish CArdioPulmonary bioImage Study, SCAPIS, is a nationwide, open-access, population-based cohort for the study of cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD).

A total of 30,154 men and women in Sweden, from 50 to 64 years old, have been recruited and investigated with detailed imaging and functional analyses of the cardiovascular and pulmonary systems. The first public release of data is planned for March 17, 2021. All researchers based in Sweden, or international researchers in collaboration with a researcher based in Sweden, will then be able to apply for data.

The novelty and significant contribution of SCAPIS is that it combines size with extensive phenotyping. The aim of SCAPIS is to predict and prevent CVD and CPD. The goal is to further develop individualized treatment and improve health care by building this research resource.

SCAPIS is a unique study made possible through a collaborative effort between six Swedish universities (Uppsala University, Umeå University, Linköping University, Lund University, University of Gothenburg and Karolinska Institutet) and university hospitals (Uppsala University Hospital, University Hospital of Umeå, Linköping University Hospital, Skåne University Hospital, Sahlgrenska University Hospital and Karolinska University Hospital).

The main funder of SCAPIS is the Swedish Heart-Lung Foundation, with considerable support from the Knut and Alice Wallenberg Foundation, Vinnova, The Swedish Research Council and the participating Universities and University Hospitals.